EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

530. Compassionate Use of Skin Cell Suspension Autografts in Major Burns: A Single-center, US Experience

Hope Werenski, Jeffrey E Carter, Anju Saraswat, John Kevin Bailey, James H Holmes, IV

Journal of Burn Care & Research · 06.04.2026 · 47 (Supplement_1) · S202-S202

DOI: 10.1093/jbcr/irag033.227 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Burn Care & Research, online erschienen am 06.04.2026. Verfasst von Hope Werenski und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Split-thickness autografts (STAG) remain the standard for closure of deep burns but are constrained by limited donor skin. At an expansion ratio of 80:1, non-cultured, autologous, skin cell suspension autografts (SCSA) allow for grafting with a reduction in donor skin. We report our single-center experience with SCSA as an adjunct to STAG in major burns.

Methods

From 2014-2018, under an FDA-approved compassionate use (CU) protocol, 17 adults (≥40% TBSA) and 13 children (≥20% TBSA) were treated with SCSA at an ABA-verified burn center. SCSA was sprayed over widely meshed STAG and donor sites. Outcomes for treated adults were compared to controls from our Burn Registry, while treated children were compared to controls from the Burn Care Quality Platform (BCQP). Primary outcomes included length of stay (LOS) normalized to %TBSA and number of operations.

Results

Seventeen adults (mean age 37 y, mean burn size 60% TBSA) [Table 1] and 13 children (mean age 3.5 y, mean burn size 39% TBSA) [Table 2] were treated under the CU SCSA protocol, with no deaths. Mean inpatient LOS per %TBSA was significantly reduced in adults treated with SCSA compared to controls (1.1 ± 0.6 d/%TBSA vs 1.9 ± 0.7 d/%TBSA, p=.001), while there was no observed difference for children. Notably, ~60% of our CU SCSA pediatric cases involved abuse/neglect or had other non-burn care issues requiring intensive social services that extended LOS beyond medical need. Finally, pediatric patients treated with SCSA underwent significantly fewer burn operations compared to controls (3 ± 2 vs 8 ± 8, p=.0001), while there was no observed difference for adults.

Conclusions

In major burns, SCSA was feasible, safe, and associated with reduced LOS in adults and fewer operations in children. These findings support further study of SCSA as an adjunct to STAG in resource-intensive burn care. Applicability of Research to Practice SCSA combined with STAG may reduce LOS and operative burden in major burns, thus improving outcomes and efficiency in modern burn care. Funding for the study N/A.

Zitieren

APA

Werenski, H., Carter, J. E., Saraswat, A., Bailey, J. K., Holmes, J. H., & IV (2026). 530. Compassionate Use of Skin Cell Suspension Autografts in Major Burns: A Single-center, US Experience. Journal of Burn Care & Research, 47(Supplement_1), S202-S202. https://doi.org/10.1093/jbcr/irag033.227

Vancouver

Werenski H, Carter JE, Saraswat A, Bailey JK, Holmes JH, IV. 530. Compassionate Use of Skin Cell Suspension Autografts in Major Burns: A Single-center, US Experience. Journal of Burn Care & Research. 2026;47(Supplement_1):S202-S202. doi:10.1093/jbcr/irag033.227

BibTeX
@article{Werenski2026,
  author = {Werenski, Hope and Carter, Jeffrey E and Saraswat, Anju and Bailey, John Kevin and Holmes, James H and IV},
  title = {530. Compassionate Use of Skin Cell Suspension Autografts in Major Burns: A Single-center, US Experience},
  journal = {Journal of Burn Care & Research},
  year = {2026},
  volume = {47},
  number = {Supplement_1},
  pages = {S202--S202},
  doi = {10.1093/jbcr/irag033.227}
}
Kostenlos starten →